These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm? ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508 [TBL] [Abstract][Full Text] [Related]
3. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Dimopoulos K; Inuzuka R; Goletto S; Giannakoulas G; Swan L; Wort SJ; Gatzoulis MA Circulation; 2010 Jan; 121(1):20-5. PubMed ID: 20026774 [TBL] [Abstract][Full Text] [Related]
4. Iron deficiency is associated with adverse outcome in Eisenmenger patients. Van De Bruaene A; Delcroix M; Pasquet A; De Backer J; De Pauw M; Naeije R; Vachiéry JL; Paelinck B; Morissens M; Budts W Eur Heart J; 2011 Nov; 32(22):2790-9. PubMed ID: 21606083 [TBL] [Abstract][Full Text] [Related]
5. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005 [TBL] [Abstract][Full Text] [Related]
6. Routine anticoagulation is not indicated for postoperative general thoracic surgical patients with new-onset atrial fibrillation. Makhija Z; Allen MS; Wigle DA; Shen KR; Cassivi SD; Nichols FC; Deschamps C Ann Thorac Surg; 2011 Aug; 92(2):421-6; discussion 426-7. PubMed ID: 21801903 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. Hopkins WE; Ochoa LL; Richardson GW; Trulock EP J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):100-5. PubMed ID: 8820089 [TBL] [Abstract][Full Text] [Related]
9. Twenty years' single-center experience with mechanical heart valves: a critical review of anticoagulation policy. Van Nooten GJ; Caes F; François K; Van Bellleghem Y; Bové T; Vandenplas G; Taeymans Y J Heart Valve Dis; 2012 Jan; 21(1):88-98. PubMed ID: 22474748 [TBL] [Abstract][Full Text] [Related]
10. A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at Fontan completion. Ballweg JA; Dominguez TE; Ravishankar C; Gaynor JW; Nicolson SC; Spray TL; Tabbutt S J Thorac Cardiovasc Surg; 2010 Sep; 140(3):537-44. PubMed ID: 20723722 [TBL] [Abstract][Full Text] [Related]
11. Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: factors that influence survival. Maltais S; Schaff HV; Daly RC; Suri RM; Dearani JA; Sundt TM; Enriquez-Sarano M; Topilsky Y; Park SJ J Thorac Cardiovasc Surg; 2011 Nov; 142(5):995-1001. PubMed ID: 21855899 [TBL] [Abstract][Full Text] [Related]
13. Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcome. Barginear MF; Lesser M; Akerman ML; Strakhan M; Shapira I; Bradley T; Budman DR Clin Appl Thromb Hemost; 2009; 15(3):263-9. PubMed ID: 18385149 [TBL] [Abstract][Full Text] [Related]
14. Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study. Hascoet S; Fournier E; Jaïs X; Le Gloan L; Dauphin C; Houeijeh A; Godart F; Iriart X; Richard A; Radojevic J; Amedro P; Bosser G; Souletie N; Bernard Y; Moceri P; Bouvaist H; Mauran P; Barre E; Basquin A; Karsenty C; Bonnet D; Iserin L; Sitbon O; Petit J; Fadel E; Humbert M; Ladouceur M Arch Cardiovasc Dis; 2017 May; 110(5):303-316. PubMed ID: 28286190 [TBL] [Abstract][Full Text] [Related]
15. Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study. Chan V; Jamieson WR; Lam BK; Ruel M; Ling H; Fradet G; Mesana TG J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1053-8.e2. PubMed ID: 20546795 [TBL] [Abstract][Full Text] [Related]
16. Quality of anticoagulation monitoring in nonvalvular atrial fibrillation patients: comparison of anticoagulation clinic versus usual care. Nichol MB; Knight TK; Dow T; Wygant G; Borok G; Hauch O; O'Connor R Ann Pharmacother; 2008 Jan; 42(1):62-70. PubMed ID: 18094348 [TBL] [Abstract][Full Text] [Related]
17. The impact of body mass index on morbidity and short- and long-term mortality in cardiac valvular surgery. Thourani VH; Keeling WB; Kilgo PD; Puskas JD; Lattouf OM; Chen EP; Guyton RA J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1052-61. PubMed ID: 21450310 [TBL] [Abstract][Full Text] [Related]
19. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Diller GP; Dimopoulos K; Broberg CS; Kaya MG; Naghotra US; Uebing A; Harries C; Goktekin O; Gibbs JS; Gatzoulis MA Eur Heart J; 2006 Jul; 27(14):1737-42. PubMed ID: 16793921 [TBL] [Abstract][Full Text] [Related]
20. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]